(Q33390631)

26 July 2017

title

Binding and uptake of A beta1-42 by primary human astrocytes in vitro (English)

1 reference

26 July 2017

0 references

0 references

4

Sabina Janciauskiene

1 reference

26 July 2017

Henrietta M Nielsen

1

1 reference

26 July 2017

Robert Veerhuis

series ordinal

2

1 reference

26 July 2017

Bo Holmqvist

series ordinal

3

1 reference

26 July 2017

publication date

1 July 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

57

1 reference

26 July 2017

issue

9

1 reference

26 July 2017

page(s)

978-988

1 reference

Serum inflammatory proteins and cognitive decline in older persons.

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Effects of Alzheimer's peptide and α1-antichymotrypsin on astrocyte gene expression

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Specificity in recognition of amyloid-beta peptide by the serpin-enzyme complex receptor in hepatoma cells and neuronal cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Immune function of astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Minocycline does not affect amyloid beta phagocytosis by human microglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

?1-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

The inflammation-sensitive protein alpha 1-anti-chymotrypsin neutralizes fibrillar aggregation and cytotoxicity of the beta-amyloid peptide more effectively than alpha 1-antitrypsin.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Neuroserpin binds Abeta and is a neuroprotective component of amyloid plaques in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

An enzyme-release assay for natural cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Inhibition of A beta fibril formation and A beta-induced cytotoxicity by senile plaque-associated proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Gene expression patterns in in vivo normal adult astrocytes compared with cultured neonatal and normal adult astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Abeta species removal after abeta42 immunization

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Leucine-rich glioma inactivated 3 is involved in amyloid beta peptide uptake by astrocytes and endocytosis itself

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Immunohistological study of senile brains by using a monoclonal antibody recognizing ? amyloid precursor protein: significance of granular deposits in relation with senile plaques

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Astrocyte apoptosis: implications for neuroprotection

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Spatial relationships between astrocytes and classical plaque components

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

A culture model of reactive astrocytes: increased nerve growth factor synthesis and reexpression of cytokine responsiveness.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Diffuse plaques associated with astroglial amyloid beta protein, possibly showing a disappearing stage of senile plaques.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20822

7 January 2021

Identifiers

DOI

10.1002/GLIA.20822

1 reference

26 July 2017

1 reference